UNI-EN 65:Notification of sale of Treasury shares of "Sopharma" AD
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 65 | / | 2024 | |||||||
| Date of issue: | 2024-06-26 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification of sale of Treasury shares of "Sopharma" AD | |||||||||||
| Official market - legal basis | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| Sofia, Bulgaria – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 25, 2024 the Company sold 710 000 (seven hundred and ten thousand) repurchased own shares representing 0.40% of the share capital of the Company, at a total value of BGN 4 217 400,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,94. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report_65_treasury shares_espi.pdf Current report_65_treasury shares_espi.pdf | Notification of sale of Treasury shares of "Sopharma" AD | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2024-06-26 | Ognian Donev | Executive director | |||
Cena akcji Sopharma AD
Cena akcji Sopharma AD w momencie publikacji komunikatu to 13.1004 PLN. Sprawdź ile kosztuje akcja Sopharma AD aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma AD.
